Unipolar depression, also more commonly known as "major" or "clinical" depression, is so called in order to distinguish it from bipolar disorder, to which it is closely related: a person is deemed to be afflicted by bipolar disorder when periods spent suffering from the same symptoms as someone who is clinically depressed are punctuated by bouts of mania. The terminology clearly relies on the view of mood states resting on a linear scale whose extremes are major depression and mania, with "normal" moods to be found inbetween.
A diagnosis of
Here I have paraphrased the actual words of the official diagnostic manual
(DSM IV). The apparent repetition, lack of clarity (i.e. what constitutes
difficulty in concentrating), and apparent covering of opposites by symptoms
3,4 and 5, show either that the diagnostic category is ill-defined or that the
condition is hard to recognize/distinguish from "normal" types. A combination
of the two explanations probably gets closer to the truth. Suffice it to say
that the best diagnosis in this case is often made by the patient him/herself
- if you are suffering from unipolar depression, you know about it: it can
be extremely debilitating.
Studies show that between 1 in 20 and 1 in 10 people do know about it
at some point during their lives. It is a recurrent disorder, to which
people of a lower socioeconomic status and women are more prone (proof
if proof were needed perhaps that money can make you happy). Success
does not make you immune, however, and one way in which clinical
depression can be easily distinguished from natural depression
(following a death, etc.) or depression associated with other
psychological problems, is that the sufferer really has nothing to be
depressed about - there are a large number of celebrities
who have suffered from unipolar disorder, for example,
Jim Carrey, who has suffered from unipolar depression.
Before discussing the two most popular approaches to treating
depression, namely cognitive therapy and drug therapy, I should at
least pay lip service to other methods: psychoanalysis, based on
the works of Freud
or Jung, or other such luminaries, has
generally been discredited, takes forever, and is often
unsuccessful. electroconvulsive therapy (ECT), popularized
earlier this century, is still used in cases of severe depression when
all else has failed. Psychodynamic therapy, which focuses on
the patient's interpersonal behaviour (social skills), can be thought
of as a subset of cognitive therapy.
The cognitive theory of depression can be seen as a formalisation/elaboration
of the idea that people are depressed because they seem to "see
the worst in
everything". Aaron Beck, a pioneer of this approach in
the sixties, suggested a three component model of the depressive's mindset:
Beck proposed that the feedback loops between these components of
the depressive mindset could be broken by getting the patient to recognize
that his way of interpreting events does not correspond with reality.
By offering alternative interpretations of the same event, the therapist
highlights the patient's biased way of thinking, thus weakening support for
the negative schemata. At the same time, the therapist urges changes in
behaviour which may again help rectify negative ways of thinking.
The main recommendation for cognitive therapy is that depressive patients have
been shown to have cognitive biases and negative schemata which can be quickly
extinguished once addressed (typically in 4-6 sessions). With new ways of
interpreting events, suggested by the therapist, the patient is
cured, empowered and thus
armed against any recurrence of the symptoms. The success of this
approach has recently led the resource-deficient NHS to produce a so
that people can "cure themselves", by understanding and using the theory
outlined above.
Advocates of drug therapy support the biological theory of depression, which
holds that it is caused by a deficiency of (a) certain type(s) of
neurotransmitter in the brain. This theory is supported by the observation
that (so-called "endogynous") depression can run in families, and by twin
studies, which seemingly confirm that the problem has a genetic component.
The genetic underpinnings of unipolar depression, and all other mental
disorders for that matter, have not yet been identified, although part of the
promise of the Human Genome Project is that they will be.
Serotonin
is the neurotransmitter whose role in determining an individual's mood
has recently been stressed above all others. Animal studies showing
that subordinate monkeys, low in the social hierarchy, are deficient
in it, compared to their dominant counterparts, are used as evidence
that this is the case. A class of drugs known as Selective Serotonin
Reuptake Inhibitors (SSRI's), of which fluoxetine, brand name Prozac,
is the most well-known, optimize the function of delivery across
synapses via serotonin by inhibiting its reuptake after a neuron has
fired. Its success in treating unipolar depression is
well-documented. There is a suspicion that it is over-prescribed,
owing to the relatively mild side effects compared to those caused by
previous antidepressant drugs (e.g. tricyclics and MOAI's). Some
sufferers do claim to have been affected very badly by it, although it seems
that most find it to be a God-send. However, despite claims that it is
non-addictive, it may be mentally addictive, as many seem to find it
hard to stop taking the drug without recurrence of symptoms - I
suspect that this is likely because it is often used without any
counselling to accompany it. Furthermore, there may be a psychological
effect at work - if you began taking a pill because of a deficiency of
a certain substance, why should the deficiency, and thus the symptoms,
not reoccur?
Interestingly, Prozac seems to be the ideal partner for that
other popular 1990's
mood-altering substance, namely MDMA, or ecstasy, which floods the brain with
serotonin when taken, but leads to damage of serotonin receptors with
repeated use. Prozac is therefore clearly the best drug for those who
experience mood disorders as a result of Ecstasy use.
COGNITIVE THERAPY
DRUG THERAPY
Daniel Read, updated on 12th February 1998